15 Jul 2019 | 11:23 am | 1 min. read
Pinsent Masons continues its expansion in Dublin office with Life Sciences and Technology Litigation hire
International law firm Pinsent Masons has boosted its pan European life sciences and technology sector capabilities with the appointment of Michael Finn as partner in its Dublin office.
Michael will be joining from Matheson, where he leads its IP disputes group and previously established its life sciences regulatory and litigation practice.
Michael advises on complex domestic and international commercial disputes, contentious intellectual property matters, data privacy disputes, regulatory matters including prosecutions, product liability, and judicial review. He has extensive experience in large-scale litigation before the Irish Commercial Court.
A valuable addition to the Dublin IP and data team, he will work alongside IP and data litigation specialist Ann Henry to enhance the firm's Big Pharma offering in Dublin.
Clare Tunstall, Head of Life Sciences at Pinsent Masons said:
"We are continuing to invest in appointing talented individuals who bolster our ability to service our international client base. Pinsent Masons has a pan European team of lawyers specialising in Life Sciences & Healthcare who advise across a range of IP, transactional and regulatory matters and Michael's stellar reputation and experience makes him a fantastic addition to our team."
During his career, Michael has acted for some of the largest organisations in the Life Sciences and technology sectors. His work includes advising technology companies on the convergence of tech, life sciences and medical device laws. He has acted in IP litigation for some of the world’s best known technology brands, and has advised one of the world’s largest life sciences companies in the defence of product liability litigation relating to a market-leading immunology product.
Gayle Bowen, Head of Pinsent Masons' Dublin office adds:
"Michael is a recognised leading practitioner who brings sector knowledge and expertise that is unmatched in the Irish market. His diverse experience complements Pinsent Masons' international Advanced Manufacturing and Technology sector and is a valuable addition to our Dublin office."
Michael's appointment continues the expansion of Pinsent Masons' Dublin office, and follows the firm's recent recruitment of Corporate Financial Services partner Naoise Harnett.
In May, the firm also announced the appointment of Robert Vidal to its London office, enhancing its competition law expertise within the life sciences sector.
Multinational law firm Pinsent Masons has hired Gillian Harrington to join the firm’s Aberdeen office as employment partner from 6 May.
Multinational law firm Pinsent Masons has hired corporate partner, Rachel Soundy, to join the firm’s Birmingham office.
Multinational law firm, Pinsent Masons LLP, has advised IGCF VI Euro, L.P. a sub-fund of Balbec Capital LP, a global alternative investment manager headquartered in the United States on its first European public securitisation in relation to the issuance of notes totalling EUR 392 million backed by a portfolio of reperforming Spanish mortgage loans, arranged by Goldman Sachs.
Pinsent Masons has appointed Judith Krens (Partner, Amsterdam) and Tom Nener (Partner, Birmingham) as co-leads of the Global Intellectual Property (IP) team, and has appointed Charlotte Weekes (Partner, London) as Head of Life Sciences. The appointments come in light of the upcoming departure of Clare Tunstall, the current Head of IP and Life Sciences, who will be leaving the firm in the Autumn.
Multinational law firm Pinsent Masons has appointed litigation partner Melanie Ryan to join its Global Investigations team in London.
Multinational law firm Pinsent Masons has advised Sandoz on the acquisition of the remaining shares in Rowex Limited, a joint venture in Ireland between Sandoz and Rowa Pharmaceuticals.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]
